Investigational Stem Cell Treatment Facility Has Success With Macular Degeneration

Share Article

Stem Cells For Hope is a leading stem cell treatment facility offering regenerative stem cell transplantation to patients looking for alternative treatments to their illnesses, and has had a recent breakthrough with the treatment of Wet Macular Degeneration.

Started in 2005 by Peter K. Sidorenko, Stem Cells For Hope (SCFH) has been working to break new ground in the field of Stem Cell Transplantation Therapy. SCFH is a leader in providing stem cell treatments and regenerative stem cell transplantation to patients looking for alternative treatments to their degenerative conditions via their international network of doctors, clinics and hospital facilities. Medical conditions that have been treated with Stem Cell Therapy include MS, Parkinson's, stroke, macular degeneration, optic nerve damage, and diabetes. Other conditions are evaluated by the Medical Advisory Board on a per case basis.

Treating patients with a wide range of serious injuries, biological, neurological, genetic and other debilitating disorders, SCFH engages in research, product development and the global treatment of their patients via Stem Cell Transplantation Therapy. Recently, they have experienced great success with a 74-year-old female from Kentucky who had been diagnosed with the wet version of Macular Degeneration in 2002.

Currently in the U.S., Stem Cell Transplantation Therapy is not FDA approved for the treatment of human patients except in the cases of leukemia and bone marrow cancer in children. While the U.S. uses embryonic stem cells for research and testing purposes on animals, "it will still be 12 to 15 years until any kind of stem cells will be authorized here for actual treatments. That's a long time to wait with nothing in sight for help [for patients,]" says Peter K. Sidorenko.

Though the company pays taxes in the U.S., due to the current legal restrictions in the United States, Mr. Sidorenko, and his partner Walter Kravchenko, offer SCFH's services to their patients outside of the U.S. in Mexico and Eastern Europe. According to Mr. Sidorenko "the clinics and hospitals that we have on our network have 15-18 years of experience in treating human patients with stem cells. Each location has a slightly different treatment protocol depending on the patient's condition. We learn from the different clinics treating physicians."

Stem Cells For Hope has a distinguished and diverse Medical and Scientific Advisory Board which is comprised of Surgeons, MD's, Ph.D.'s, scientists and research fellows who are responsible for patient evaluations, producing abstracts on the medical conditions and treatment of patients. They hope to develop research papers to be published in various medical publications and journals, and prepare patent applications that will go before the FDA shortly.
STFH is currently looking for additional prime, successful, international locations to add to their network of service providers. 

For additional information regarding Stem Cells For Hope Please Contact Walter Kravchenko and Peter Sidorenko.

Stem Cells For Hope
Walter Kravchenko, Chairman and CEO
631 929 3900

Peter Sidorenko
Chief Operating Officer
631 929 3900

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Walter Kravchenko

Peter Sidorenko
Visit website